Hence, such TAA-AAbs may be successfully used for various diagnostic purposes in general oncology apart from the clinical context of the cancer-associated autoimmunity, as exemplified by HuD/ELAVL4 antigen representing one of seven TAAs in the EarlyCDT®-Lung panel (see Section 3.2). The gene discussed is ELAVL4; the disease is cancer.